M. Drent (Md Ede, Netherlands), H. Nunes (Bobigny, France)
Imbalance of M1/M2 alveolar macrophages phenotype in pulmonary sarcodosis
S. Lyamina, N. Demianenko, S. Shelukhina, O. Lovacheva, E. Shmelev, I. Malyshev (Moscow, Russian Federation)
|   |
Pulmonary granuloma infiltration in sarcoidosis, inflamatory markers and domestic exposure to fungi
M. Tercelj-Zorman, B. Salobir, M. Zupancic, B. Wraber, R. Rylander (Ljubljana, Slovenia; Lerum, Sweden)
|  |
Relapse after discontinuation of infliximab in sarcoidosis patients can be predicted by PET-scan and sIL-2R
A. D. M. Vorselaars, A. Verwoerd, C. H. M. Van Moorsel, R. G. M. Keijsers, G. T. Rijkers, J. C. Grutters (Nieuwegein, Middelburg, Utrecht, Netherlands)
| |
V158F polymorphism of FCGR3A gene in the etiopathogenesis of sarcoidosis
M. Typiak, K. Rebala, A. Sternau, M. Dudziak, J. M. Slominski, A. Dubaniewicz (Gdansk, Poland)
| |
Are there differences in the functional polymorphism of FCGR3A gene between sarcoidosis and tuberculosis?: Preliminary study
P. Klimont, M. Typiak, K. Rebala, M. Dudziak, A. Dubaniewicz, B. Rekawiecki (Gdansk, Poland)
| |
Phenotypic plasticity of alveolar macrophages in pulmonary sarcoidosis
S. Lyamina, N. Demianenko, S. Shelukhina, O. Lovacheva, E. Shmelev, I. Malyshev (Moscow, Russian Federation)
| |
Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
N. Milman, T. van Overeem Hansen, M. Skov Jensen, C. Bo Svendsen, K. Richter Larsen (Copenhagen, Viborg, Denmark)
| |
ACE and sIL2-R predict lung function improvement in sarcoidosis during methotrexate therapy
A. D. M. Vorselaars, C. H. M. Van Moorsel, P. Zanen, H. J. T. Ruven, A. Claessen, H. van Velzen-Blad, J. C. Grutters (Nieuwegein, Utrecht, Netherlands)
| |